This is what cheerleaders were posting in 2002 (when I bought this stock) and it plunged from $30 to $4. History teaches us that EMIS management cannot execute, and EMIS investors never get rich unless they short at the right time.
More sound thinking from Camaro - any pharma company that has had a failed phase III trial is not worth investing in ever again. I'm guessing that would eliminate most of the pharma companies out there. Any other investing rules you want to enlighten us with?